PT Diastika Biotekindo Tbk (IDX:CHEK)
Indonesia · Delayed Price · Currency is IDR 134.00
0.00 (0.00%)
Last updated: Sep 2, 2026, 11:10 AM WIB
IDX:CHEK Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 205,273 | 201,306 | 154,792 | 129,098 | 117,468 | |
Revenue Growth | 19.84% | 30.05% | 19.90% | 9.90% | - |
Cost of Revenue | 127,242 | 128,324 | 96,746 | 83,141 | 76,290 |
Gross Profit | 78,030 | 72,982 | 58,046 | 45,956 | 41,178 |
Selling, General & Admin | 58,710 | 51,811 | 38,167 | 33,563 | 27,836 |
Other Operating Expenses | 1,842 | 1,842 | 515.71 | 277.27 | 120.65 |
Operating Expenses | 60,551 | 53,652 | 38,683 | 33,840 | 27,957 |
Operating Income | 17,479 | 19,330 | 19,363 | 12,117 | 13,221 |
Interest Expense | -1,390 | -315.82 | -258.55 | -32.73 | -0.15 |
Interest & Investment Income | 2,321 | 1,169 | 183.57 | 260.67 | 331.56 |
Currency Exchange Gain (Loss) | -1,509 | -1,509 | 261.69 | -514.78 | 626.84 |
Other Non Operating Income (Expenses) | -252.84 | -269.37 | -268.98 | 5,542 | -47.41 |
EBT Excluding Unusual Items | 16,648 | 18,405 | 19,281 | 17,371 | 14,132 |
Gain (Loss) on Sale of Assets | - | - | 5.59 | 169.2 | 2,627 |
Pretax Income | 16,648 | 18,405 | 19,287 | 17,540 | 16,759 |
Income Tax Expense | 4,382 | 4,382 | 4,112 | 3,950 | 3,723 |
Net Income | 12,267 | 14,023 | 15,175 | 13,591 | 13,035 |
Net Income to Common | 12,267 | 14,023 | 15,175 | 13,591 | 13,035 |
Net Income Growth | -43.97% | -7.59% | 11.65% | 4.26% | - |
Shares Outstanding (Basic) | 4,033 | 4,113 | 2,512 | 2,512 | 2,512 |
Shares Outstanding (Diluted) | 4,033 | 4,113 | 2,512 | 2,512 | 2,512 |
Shares Change | 41.07% | 63.77% | - | - | - |
EPS (Basic) | 3.04 | 3.41 | 6.04 | 5.41 | 5.19 |
EPS (Diluted) | 3.04 | 3.41 | 6.04 | 5.41 | 5.19 |
EPS Growth | -60.29% | -43.57% | 11.65% | 4.26% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | -75,117 | -71,369 | -1,934 | 3,330 | 534.23 |
Free Cash Flow Per Share | -18.62 | -17.35 | -0.77 | 1.33 | 0.21 |
Gross Margin | 38.01% | 36.25% | 37.50% | 35.60% | 35.05% |
Operating Margin | 8.52% | 9.60% | 12.51% | 9.39% | 11.25% |
Profit Margin | 5.98% | 6.97% | 9.80% | 10.53% | 11.10% |
Free Cash Flow Margin | -36.59% | -35.45% | -1.25% | 2.58% | 0.46% |
EBITDA | 33,817 | 32,643 | 26,972 | 17,460 | 18,775 |
EBITDA Margin | 16.47% | 16.21% | 17.42% | 13.53% | 15.98% |
D&A For EBITDA | 16,339 | 13,313 | 7,609 | 5,343 | 5,553 |
EBIT | 17,479 | 19,330 | 19,363 | 12,117 | 13,221 |
EBIT Margin | 8.52% | 9.60% | 12.51% | 9.39% | 11.25% |
Effective Tax Rate | 26.32% | 23.81% | 21.32% | 22.52% | 22.22% |